Regulatory decisions pertaining to aprotinin may be putting patients at risk.

Paul C Hébert Dean A Fergusson Brian Hutton C David Mazer Stephen Fremes Morris Blajchman Charles MacAdams George Wells Jim Robblee Jean Bussières Kevin Teoh

CMAJ

Centre de Recherche (Hébert), Centre Hospitalier de L'Université de Montréal, Montréal, Que.; Département de Médecine (Hébert), Université de Montréal, Montréal, Que.; Clinical Epidemiology Program (Fergusson), Ottawa Hospital Research Institute, Ottawa, Ont.; Department of Medicine (Fergusson, Hutton, Mazer), University of Ottawa, Ottawa, Ont.; Department of Anesthesia (Fremes), Keenan Center/Li Ka Shing Institute, St. Michael's Hospital, University of Toronto, Toronto, Ont.; Sunnybrook Health Sciences Centre, Department of Surgery (Blajchman), Division of Cardiac and Vascular Surgery, University of Toronto, Toronto, Ont.; Department of Pathology and Molecular Medicine (MacAdams), McMaster University, Hamilton, Ont.; Libin Cardiovascular Institute (Wells), University of Calgary, Calgary, Alta.; University of Ottawa Heart Institute (Robblee), Ottawa, Ont.; Hôpital Laval (Bussières), Institut Universitaire de Cardiologie et Pneumologie de l'Université Laval, Laval, Que.; Hamilton Health Science Centre (Teoh), McMaster University, Hamilton, Ont.

Published: December 2014

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259771	PMC
http://dx.doi.org/10.1503/cmaj.131582	DOI Listing

Publication Analysis

Top Keywords

regulatory decisions

decisions pertaining

pertaining aprotinin

aprotinin putting

putting patients

patients risk

regulatory

pertaining

aprotinin

putting

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!